The SGZ method was also applied to predict the clonality and zygosity of 12 ESR1 mutations in estrogen receptor positive breast cancer biopsies and determined these ESR1 mutations to be somatically acquired, clonal biomarkers of endocrine resistance [23]. Here, ESR1 is linked to breast cancer.